semaglutide fda - Search News

Semaglutide shortage ends

Hosted on MSN · 2d

Semaglutide shortage ends as FDA sets deadline for compounders

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed – for now.

FDA Announces End to Semaglutide Shortage, Impacting Compounders and Telehealth Providers Offering Injectable GLP-1 Drugs

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a

FiercePharma · 2d

Compounders sue FDA again over declaring end of shortage for Novo's semaglutide

Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight. | Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight.

Top in endocrinology: Semaglutide shortage ends; rise in diabetes in low-income countries

The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...

1d

Novo Nordisk's Ozempic And Wegovy No Longer on FDA Shortage List, Faces Lawsuit Over Decision

A lawsuit challenges the FDA's decision to remove semaglutide from the shortage list, alleging it was arbitrary and harms ...

Lilly expands its Zepbound vial offering, as Hims pulls back on semaglutide

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...

22h

Hims & Hers: Brace For Impact As It Faces A Possible 18% Revenue Hit

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results